Covered recipient · General Payments record
AMANDA C GUIDON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$61,235.14
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $31,217.50 | 8 |
| Travel and Lodging | $1,654.85 | 10 |
| Food and Beverage | $619.78 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $18,139.01 | 18 |
| Alexion Pharmaceuticals, Inc. | $12,681.50 | 5 |
| ARGENX US, INC. | $2,187.50 | 1 |
| Regeneron Pharmaceuticals, Inc. | $484.12 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018202020212022
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $5,900.00 | 05/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093914492 | CMS |
| Alexion Pharmaceuticals, Inc. | $1,770.00 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1093923044 | CMS |
| Alexion Pharmaceuticals, Inc. | $280.85 | 10/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1093900438 | CMS |
| Alexion Pharmaceuticals, Inc. | $10.65 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093947090 | CMS |
| Alexion Pharmaceuticals, Inc. | $4,720.00 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094041255 | CMS |
| ARGENX US, INC. | $2,187.50 | 06/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142114429 | CMS |
| Regeneron Pharmaceuticals, Inc. | $289.23 | 07/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1114399607 | CMS |
| Regeneron Pharmaceuticals, Inc. | $64.41 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114399609 | CMS |
| Regeneron Pharmaceuticals, Inc. | $112.79 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114399611 | CMS |
| Regeneron Pharmaceuticals, Inc. | $17.69 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114399613 | CMS |
| UCB, Inc. | $22.83 | 03/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143203415 | CMS |
| UCB, Inc. | $46.34 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143203420 | CMS |
| UCB, Inc. | $6,400.00 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143203424 | CMS |
| UCB, Inc. | $25.00 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143203428 | CMS |
| UCB, Inc. | $50.00 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143203433 | CMS |
| UCB, Inc. | $135.00 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143203438 | CMS |
| UCB, Inc. | $23.85 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143203442 | CMS |
| UCB, Inc. | $134.05 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143203447 | CMS |
| UCB, Inc. | $18.87 | 11/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143203451 | CMS |
| UCB, Inc. | $24.14 | 11/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143203455 | CMS |
| UCB, Inc. | $35.00 | 11/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143203459 | CMS |
| UCB, Inc. | $43.60 | 11/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143203464 | CMS |
| UCB, Inc. | $45.00 | 11/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143218219 | CMS |
| UCB, Inc. | $321.58 | 11/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143218224 | CMS |
| UCB, Inc. | $573.75 | 11/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1143218228 | CMS |
| UCB, Inc. | $640.00 | 11/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143218232 | CMS |
| UCB, Inc. | $640.00 | 11/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143218237 | CMS |
| UCB, Inc. | $8,960.00 | 11/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143218241 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.